HERON THERAPEUTICS, INC. /DE/ (HRTX) Net income 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$20.2MFY2025 · since FY2016: -$173.1M → -$20.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$20.2M | -48.7% |
| FY2024 | -$13.6M | +87.7% |
| FY2023 | -$110.6M | +39.3% |
| FY2022 | -$182.0M | +17.5% |
| FY2021 | -$220.7M | +2.9% |
| FY2020 | -$227.3M | -11.0% |
| FY2019 | -$204.7M | -14.5% |
| FY2018 | -$178.8M | +9.4% |
| FY2017 | -$197.5M | -14.1% |
| FY2016 | -$173.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice